Better Clinical Results in Rheumatoid Arthritis Patients Treated Under a Multidisciplinary Care Model When Compared with a National Rheumatoid Arthritis Registry

References

• Fazal SA, Khan M, Nishi SE, et al. A clinical update and global economic burden of rheumatoid arthritis. Endocr Metab Immune Disord Drug Targets. 2018;18(2):98–109. doi:10.2174/1871530317666171114122417
   PubMed Web of Science ®Google Scholar
• van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018;32(2):174–187. doi:10.1016/J.BERH.2018.10.005
   PubMed Web of Science ®Google Scholar
• Hsieh PH, Wu O, Geue C, McIntosh E, McInnes IB, Siebert S. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Ann Rheum Dis. 2020;79(6):S771–S777. doi:10.1136/ANNRHEUMDIS-2019-216243
   PubMed Web of Science ®Google Scholar
• Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de Alto Costo Consenso Basado En La Evidencia: indicadores de Gestión Del Riesgo En Pacientes Con Artritis Reumatoide En Colombia; 2018. Available from: https://cuentadealtocosto.org/site/publicaciones/consenso-basado-en-evidencia-indicadores-de-gestion-del-riesgo-en-pacientes-con-artritis-reumatoide-en-colombia/. Accessed October 21, 2022.
   Google Scholar
• Bridges SL, Hughes LB, Mikuls TR, et al. Early rheumatoid arthritis in African-Americans: the CLEAR registry. Clin Exp Rheumatol. 2003;21(SUPPL. 31):S138–S145.
   PubMedGoogle Scholar
• Kremer J. The Corrona US registry of rheumatic and autoimmune diseases. Clin Exp Rheumatol. 2016;34(Supp101):S96–S99.
   PubMedGoogle Scholar
• Shadick NA, Gerlanc NM, Frits ML, et al. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry. Clin Rheumatol. 2019;38(11):3081–3092. doi:10.1007/S10067-019-04649-4
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Tanaka E, Nakajima A, et al. A large observational cohort study of rheumatoid arthritis, IORRA: providing context for today’s treatment options. Mod Rheumatol. 2020;30(1):1–6. doi:10.1080/14397595.2019.1660028
   PubMed Web of Science ®Google Scholar
• Curtis JR, Jain A, Askling J, et al. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum. 2010;40(1):2–14.e1. doi:10.1016/J.SEMARTHRIT.2010.03.003
   PubMed Web of Science ®Google Scholar
• Santos-Moreno P, Castillo P, Villareal L, Pineda C, Sandoval H, Valencia O. Clinical outcomes of patients with rheumatoid arthritis treated in a disease management program: real-world results. Open Access Rheumatol Res Rev. 2020;12:249–256. doi:10.2147/OARRR.S270700
   PubMed Web of Science ®Google Scholar
• Santos-Moreno P, Castañeda O, Garro B, Flores D, Sánchez G, Castro C. From the model of integral attention to the creation of centers of excellence in rheumatoid arthritis. Clin Rheumatol. 2015;34(Suppl1):71–77. doi:10.1007/S10067-015-3017-8
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Bijlsma JWJ, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631–637. doi:10.1136/ARD.2009.123919
   PubMed Web of Science ®Google Scholar
• Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15. doi:10.1136/ANNRHEUMDIS-2015-207524
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):S685–S699. doi:10.1136/ANNRHEUMDIS-2019-216655
   PubMed Web of Science ®Google Scholar
• Ministry of health and social protection. Clinical Practice Guideline for Early Detection, Diagnosis and Treatment of Rheumatoid Arthritis; 2014. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/CA/gpc-tratamiento-artritis-reumatoide-completa.pdf. Accessed October 21, 2022.
   Google Scholar
• Ministry of health and social protection. Política de Atención Integral en Salud Comprehensive Health Care Policy; 2016. Available from: https://www.minsalud.gov.co/Paginas/politica-integral-de-atencion-en-salud.aspx. Accessed October 21, 2022.
   Google Scholar
• Ministry of health and social protection. Resolution 123 of 2015; 2015. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/resolucion-0123-de-2015.pdf. Accessed October 21, 2022.
   Google Scholar
• Ministry of health and social protection. Resolución 1393 de 2015 Resolution 1393 of 2015; 2015. Available from: https://cuentadealtocosto.org/site/wp-content/uploads/2019/10/Resolucion-1393-de-2015-ARTRITIS.pdf. Accessed October 21, 2022.
   Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/ART.27584
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–324. doi:10.1002/ART.1780310302
   PubMed Web of Science ®Google Scholar
• Santos-Moreno P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, de la Hoz-Restrepo F, Alvis-Guzmán N. Centers of excellence implementation for treating rheumatoid arthritis in Colombia: a cost-analysis. Clinicoecon Outcomes Res. 2021;13:583–591. doi:10.2147/CEOR.S308024
   PubMed Web of Science ®Google Scholar
• Santos-Moreno P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, Paternina-Caicedo A, Alvis-Guzmán N. A comprehensive care program achieves high remission rates in rheumatoid arthritis in a middle-income setting. experience of a center of excellence in Colombia. Rheumatol Int. 2018;38(3):499–505. doi:10.1007/S00296-017-3903-2
   PubMed Web of Science ®Google Scholar
• Widdifield J, Paterson JM, Bernatsky S, et al. Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system. BMJ Open. 2014;4:1. doi:10.1136/BMJOPEN-2013-003888
   Web of Science ®Google Scholar
• Kvien TK, Balsa A, Betteridge N, et al. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities. RMD Open. 2020;6:2. doi:10.1136/RMDOPEN-2020-001211
   Web of Science ®Google Scholar
• Barber CEH, Then KL, Bohm V, et al. Development of a patient-centered quality measurement framework for measuring, monitoring, and optimizing rheumatoid arthritis care in Canada. J Rheumatol. 2021;48(3):326–334. doi:10.3899/JRHEUM.200688
   PubMed Web of Science ®Google Scholar
• Meisters R, Putrik P, Ramiro S, et al. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries. Ann Rheum Dis. 2020;79(11):1423–1431. doi:10.1136/ANNRHEUMDIS-2020-217520
   PubMed Web of Science ®Google Scholar
• Taylor PC, Law ST. When the first visit to the rheumatologist is established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2019;33(5):101479. doi:10.1016/J.BERH.2019.101479
   PubMed Web of Science ®Google Scholar
• Barnabe C. Disparities in rheumatoid arthritis care and health service solutions to equity. Rheum Dis Clin North Am. 2020;46(4):685–692. doi:10.1016/J.RDC.2020.07.005
   PubMed Web of Science ®Google Scholar
• Sanchez-Piedra C, Yoldi B, Valero M, Andreu JL, Díaz-González F, Gómez-Reino JJ. Status of rheumatology in Spain in 2017: 2.0 rheumatologists per 100,000 population. Reumatol Clin. 2018;14(5):311–312. doi:10.1016/J.REUMA.2017.10.003
   PubMed Web of Science ®Google Scholar
• Benham H, Rutherford M, Kirby S, et al. Treat-to-target in rheumatoid arthritis: evaluating the patient perspective using the patient opinion real-time anonymous liaison system: the RA T2T PORTAL study. Int J Rheum Dis. 2019;22(5):874–879. doi:10.1111/1756-185X.13514
   PubMed Web of Science ®Google Scholar
• Nagy G, Roodenrijs NMT, Welsing PMJ, et al. EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis. 2021;80(1):31–35. doi:10.1136/ANNRHEUMDIS-2020-217344
   PubMed Web of Science ®Google Scholar
• Owensby JK, Chen L, O’Beirne R, et al. Patient and rheumatologist perspectives regarding challenges to achieving optimal disease control in rheumatoid arthritis. Arthritis Care Res. 2020;72(7):933–941. doi:10.1002/ACR.23907
   Web of Science ®Google Scholar
• Gamboa-Cárdenas RV, Ugarte-Gil MF, Loreto M, et al. Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort. Clin Rheumatol. 2019;38(10):2737–2746. doi:10.1007/S10067-019-04618-X
   PubMed Web of Science ®Google Scholar
• Belmonte Serrano MÁ. [Is the DAS28 score the most adequate method to estimate activity in rheumatoid arthritis? Clinimetric considerations and simulations scenarios]. Reumatol Clin. 2008;4(5):183–190. Spanish. doi:10.1016/S1699-258X(08
   PubMedGoogle Scholar
• Santos-Moreno P, Caballero-Uribe CV, Cardiel MH, et al. A consensus position paper from REAL-PANLAR group about the methodological approach for the accreditation process of centers of excellence in rheumatoid arthritis in Latin America. J Clin Rheumatol. 2019;25(1):54–58. doi:10.1097/RHU.0000000000000773
   PubMed Web of Science ®Google Scholar